Antihypertensive therapy in diabetic hypertensive patients

American Journal of Hypertension

Volumn 14, Issue 5 II, 2001, Pages

  Messerli, Franz H ^a   Grossman, Ehud ^b   Goldbourt, Uri ^b,c,d  

^a OCHSNER MEDICAL CENTER   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c OCHSNER CLINIC FOUNDATION   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antihypertensive therapy; Cardiovascular morbidity; Diabetes mellitus; Hypertension; Mortality

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRENDIPINE;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; HUMAN; HYPERTENSION; MEDICAL INFORMATION; PRIORITY JOURNAL; SYSTOLIC HYPERTENSION;

EID: 0035003599     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)01314-0     Document Type: Article

References (40)

1. Type 2 diabetes mellitus: Greater cardiovascular risks and greater benefits of therapy
2. Diabetic and hypertensive heart disease
3. Diabetes mellitus and hypertension
4. Hypertension and mortality in diabetic and non-diabetic Finnish men
5. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
6. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
7. Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy
8. Hypertension in diabetic patients. An overview of interventional studies to preserve renal function
9. National High Blood Pressure Education Program Working Group report on hypertension in diabetes
10. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
11. Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function
12. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
13. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
14. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
15. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
16. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
17. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
18. Chinese trial on isolated systolic hypertension in the elderly
19. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
20. Results of the Fosinopril Versus Amlodipine Cardiovascular Events Trials (FACET) in hypertensive patients with noninsulin dependent diabetes mellitus (NIIDM)
21. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
22. High blood pressure and diabetes mellitus: Are all antihypertensive drugs created equal?
23. Determinants of progressive renal disease in diabetes mellitus
24. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six year follow-up study in Pima Indians
25. Putative risk factors associated with retinopathy in patients with diabetes diagnosed at or after 30 years of age
26. Blood pressure and the progression of mild background diabetic retinopathy
27. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients
28. Risk factors for coronary heart disease mortality among persons with diabetes
29. Left ventricular mass in diabetes - Hypertension
30. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
31. How far should blood pressure be reduced in diabetic hypertensive patients?
32. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
33. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy
34. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
35. Preserving renal function in adults with hypertension and diabetes: A consensus approach
36. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
37. Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
38. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
39. Angiotensin converting enzyme inhibitors and calcium antagonists alone or combines: Does the progression of diabetic renal disease differ?
40. The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: Focus on fixed-dose combination antihypertensive therapy